Skip to main content
. 2019 May 6;16(2):369–380. doi: 10.1007/s13311-019-00727-2

Table 1.

Pivotal clinical trials—baseline characteristics [64, 65, 85, 86, 88]

VNS (E03) VNS (E05) RNS DBS
n 114 198 191 110
Epilepsy type Focal Focal Focal Focal
Years with epilepsy 21.8 ± 9.1 22.8 ± 11.1 19.6 ± 11.4 22.3 ± 13
Seizures per month: inclusion criteria ≥ 6 ≥ 6 ≥ 3 ≥ 6 to ≤ 300
Seizures per month: observation period 45.0 (median 20.4 to 23.0)* 35.8 ± 61.5 (median 14.3 to 16.2)** 34.2 ± 61.9 (median 9.7) 56.1 ± 101 (median 19.5)
Prior surgery 31% 22.6% 32% 24.5%
No. of AEDs 2.0 ± 0.8 2.1 ± 0.7 2.9 ± 1.1 2.3 ± 0.7

*Calculated from [41] based on a 28-day month

**Calculated from [42] based on a 28-day month